The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods
暂无分享,去创建一个
H. E. Sönmez | M. Çakan | Ş. Karadağ | A. Tanatar | N. Ayaz
[1] F. Yalçınkaya,et al. Sacroiliitis in Children With Familial Mediterranean Fever , 2019, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[2] R. Papa,et al. Secondary, AA, Amyloidosis. , 2018, Rheumatic diseases clinics of North America.
[3] S. Masters,et al. An Update on Autoinflammatory Diseases: Inflammasomopathies , 2018, Current Rheumatology Reports.
[4] H. Alpay,et al. Polyarteritis nodosa in case of familial Mediterranean fever. , 2018, The Turkish journal of pediatrics.
[5] S. Özen,et al. Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management , 2017, Front. Immunol..
[6] S. Amselem,et al. Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients. , 2017, Clinical biochemistry.
[7] A. Elhan,et al. Late-onset disease is associated with a mild phenotype in children with familial Mediterranean fever , 2016, Clinical Rheumatology.
[8] S. Ozen,et al. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review , 2016, Rheumatology International.
[9] H. Şenol,et al. Could pentraxin-3 be a new marker for subclinical inflammation in familial Mediterranean fever? , 2015, Pediatric Rheumatology.
[10] N. Wulffraat,et al. Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever , 2015, Annals of the rheumatic diseases.
[11] M. Fändrich,et al. AA Amyloidosis : Pathogenesis and Targeted Therapy Gunilla , 2014 .
[12] A. Elhan,et al. Can colchicine response be predicted in familial Mediterranean fever patients? , 2014, Rheumatology.
[13] A. Martini,et al. Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype , 2013, Annals of the rheumatic diseases.
[14] N. Akar,et al. The value of procalcitonin measurements in children with familial Mediterranean fever , 2012, Rheumatology International.
[15] I. Ben-Zvi,et al. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy , 2011, Nature Reviews Rheumatology.
[16] C. Cray,et al. Acute phase response in animals: a review. , 2009, Comparative medicine.
[17] A. Elhan,et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. , 2009, Rheumatology.
[18] B. Reichman,et al. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever. , 2007, Seminars in arthritis and rheumatism.
[19] Caroline A Sabin,et al. Natural history and outcome in systemic AA amyloidosis. , 2007, The New England journal of medicine.
[20] A. Elhan,et al. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study , 2007, Rheumatology International.
[21] D. Booth,et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.
[22] J. Baehring. Laboratory Investigations , 2005, Journal of Neuro-Oncology.
[23] S. Akpek,et al. Polyarteritis nodosa in a case of familial Mediterranean fever , 2004, Pediatric Nephrology.
[24] A. Bakkaloğlu,et al. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. , 2003, Clinical and experimental rheumatology.
[25] A. Larsson,et al. Correlations between serum amyloid A protein and C‐reactive protein in infectious diseases , 2003, Scandinavian journal of clinical and laboratory investigation.
[26] H. Yazici,et al. Acute phase response in familial Mediterranean fever , 2002, Annals of the rheumatic diseases.
[27] Ian Todd,et al. Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.
[28] A. Komatsuda,et al. [Secondary (AA) amyloidosis]. , 1998, Ryoikibetsu shokogun shirizu.
[29] D. Zemer,et al. Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.